John Celebi

2021

In 2021, John Celebi earned a total compensation of $6.9M as President and Chief Executive Officer at Sensei Biotherapeutics.

Compensation breakdown

Non-Equity Incentive Plan$264,000
Option Awards$6,116,715
Salary$487,068
Other$41,912
Total$6,909,695

Celebi received $6.1M in option awards, accounting for 89% of the total pay in 2021.

Celebi also received $264K in non-equity incentive plan, $487.1K in salary and $41.9K in other compensation.

Rankings

In 2021, John Celebi's compensation ranked 1,784th out of 12,406 executives tracked by ExecPay. In other words, Celebi earned more than 85.6% of executives.

ClassificationRankingPercentile
All
1,784
out of 12,406
86th
Division
Manufacturing
661
out of 5,492
88th
Major group
Chemicals And Allied Products
246
out of 2,368
90th
Industry group
Drugs
207
out of 2,089
90th
Industry
Pharmaceutical Preparations
141
out of 1,536
91st
Source: SEC filing on June 15, 2023.

Celebi's colleagues

We found two more compensation records of executives who worked with John Celebi at Sensei Biotherapeutics in 2021.

2021

Robert Pierce

Sensei Biotherapeutics

Former Chief R&D Officer

2021

Erin Colgan

Sensei Biotherapeutics

Chief Financial Officer

News

In-depth

You may also like